PURPOSE: To examine @entity1486 (PSA) screening patterns and outcomes in rural and urban @entity1 in New Zealand. METHODS: @entity1 aged 40+ years were identified from 18 rural and 13 urban general practices across the Midland Cancer Network region. Computerized practice records were cross-referenced with community laboratory data to ascertain the number and level of PSA tests undertaken in 2010 and 3 years prior. For @entity1 with an elevated PSA result in 2010, practice records were searched for information on specialist visits, and they were cross-referenced with histology reports regarding biopsy and @entity263 diagnosis. FINDINGS: The study population included 34,960 @entity1 aged 40+ years, of whom 48% were enrolled in rural practices. @entity1 in rural practices were 43% less likely to be screened with a PSA test in 2010, but they were 53% more likely to have an elevated PSA result. The @entity263 detection rate from all screened @entity1 was 6 per 1,000 for rural @entity1 compared with 3 per 1,000 for urban @entity1 . Rural @entity1 were more likely diagnosed with Gleason score 9 @entity5 and @entity3 . CONCLUSION: Significant differences were found in PSA screening patterns between rural and urban general practices. Due to lower screening rates, rural @entity1 were more likely to be diagnosed with @entity263 when screened and also seemed to be diagnosed with more @entity1442 compared with urban @entity1 . Despite ongoing discussions about the benefits and harms of PSA screening, PSA testing as such seems to be under-utilized in New Zealand rural practices.

Rural-Urban Differences in XXXX (PSA) Screening and Its Outcomes in New Zealand.

@entity1 :: ('9606', 'Species') :: ['Men', 'men'] @entity263 :: ('MESH:D011471', 'Disease') :: ['prostate cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumors'] @entity1442 :: ('MESH:D020178', 'Disease') :: ['advanced disease'] @entity3 :: ('MESH:D009362', 'Disease') :: ['metastatic disease'] @entity1486 :: ('354', 'Gene') :: ['prostate-specific antigen']
@entity1486 :: (354,Gene) :: ['Prostate-Specific Antigen']
